SOURCE: National Eagles and Angels Association

National Eagles and Angels Association

April 12, 2011 14:24 ET

National Eagles and Angels Association's Affiliate, NEAA Venture Research, LLC, Has Initiated Coverage on Wound Management Technologies, Inc.

HOUSTON, TX--(Marketwire - Apr 12, 2011) - The National Eagles and Angels Association (NEAA), a nationwide alliance of individual investors and business angels, today announced that its affiliate, NEAA Venture Research, LLC, has initiated coverage on Wound Management Technologies Inc. (PINKSHEETS: WNDM). The report highlights the Company's efforts in the wound healing arena.

The free research report, which is now available, can be viewed at http://eagleandangel.com/page/wp-content/uploads/2011/04/WMNewDocument3_1.pdf.

The report was written by NEAA Venture Research's Research Director, Clay Mahaffey, CFA, who said: "The Company participates in the wound care market, which is estimated at $5 billion per year. They have a product approved for use by the U.S. FDA and the patient cost is reimbursed under Medicare Part B coverage. The patented product called CellerateRX®, is an activated collagen that has been shown to be very effective in improving and healing wounds. This is the type of preventative product that actually reduces life time costs of the patient as opposed to letting the wound degenerate, become chronic and require more expensive treatments. For diabetic patients, the worst outcomes from chronic wounds are amputation and death; hopefully this product will address these serious problems. We will update our coverage as new information becomes available over the next twelve months."

About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage. More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.

About National Eagles and Angels Association (NEAA)
The National Eagles and Angels Association (NEAA) is a nationwide alliance of individual investors and business angels, each accepting the high risk while anticipating the potential high returns that can be commensurate with investment in entrepreneurial growth companies. For further information about NEAA, visit www.eagleandangel.com, call us toll-free at 888-465-NEAA (6322), or send us an email at info@eagleandangel.com.

About NEAA Venture Research, LLC
NEAA Venture Research, LLC is an independent research and consulting firm that is an affiliate of the National Eagles and Angels Association (NEAA). We offer equity research services on selected smaller capitalization companies that we believe have exceptional growth potential but typically lack conventional broker/dealer research coverage. Research services are provided on a subscription basis on selected peer group baskets of stocks for institutional investors, broker/dealers, registered advisors and other investors.

Disclosure: NEAA Venture Research is not a FINRA member or registered broker/dealer. None of the profiles issued by NEAA VR LLC constitute a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor's objectives, other securities holdings, financial situation needs, and tax status. NEAA VR LLC and National Eagles and Angels Association (an affiliated company) anticipate receiving 80,000 restricted common shares from the Company for services rendered including preparation of this report and other investor relations services. These services may include investor conferences and digital and print distribution of investor-related materials. Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. This equity research report was prepared for informational purposes only. Information is obtained from sources believed to be reliable, but its accuracy and completeness is not guaranteed. NEAA VR LLC employees and affiliates may have positions and affect transactions in the securities of the subject company.

Contact Information

  • For more information on NEAA or NEAA Venture Research, LLC:
    Call us toll-free at 888-465-NEAA (6322)
    Send us an email at Email Contact